Patent · US Active

Treatment of Alzheimer's Disease (AD) with an aluminum salt

US11147873B2 · kind B2 · utility

1Cited by

1References

14Claims

0Family size

Assignee

Advantage Therapeutics, Inc. · US

Inventors

Markus Mandler · Wien, AT
Achim Schneeberger · Fort Lauderdale, US
Frank Mattner · Wien, AT
Walter Schmidt · Wien, AT

Key dates

Filing date	Mar 17, 2020
Grant date	Oct 19, 2021
Priority date	—
Expiry date	Mar 17, 2040

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K2039/6081
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disclosed is a method for the treatment of AD, wherein an immune stimulating pharmaceutical composition comprising an aluminium salt is administered to a patient having AD or having a risk to develop AD in an effective amount.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.